|
Status |
Public on Mar 20, 2024 |
Title |
Serological mechanisms driving cardiotoxicity in COVID-19 |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
The aim of the study is to investigate the effects of serum from COVID-19 patients on pluripotent stem cells derived cardiomyocytes (PSC-CMs)
|
|
|
Overall design |
To investigate the effects of serum, PSC-CMs were treated for 4 days in the presence of serum coming from control, mild or severe COVID-19 patients. To investigate COVID-19 specific pathways, PSC-CMs were also treated with plasma coming from ARDS patients
|
|
|
Contributor(s) |
Colzani M, Williams EC, Mohorianu I, Sinha S |
Citation(s) |
38041432 |
|
Submission date |
Jul 05, 2022 |
Last update date |
Mar 20, 2024 |
Contact name |
Irina Mohorianu |
E-mail(s) |
data-submissions@stemcells.cam.ac.uk
|
Organization name |
University of Cambridge
|
Department |
Wellcome-MRC Cambridge Stem Cell Institute
|
Street address |
Puddicombe Way
|
City |
Cambridge |
ZIP/Postal code |
CB2 0AW |
Country |
United Kingdom |
|
|
Platforms (1) |
GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
|
Samples (27)
|
|
Relations |
BioProject |
PRJNA855896 |